IP Library Granted Patent US 7,521,233
Granted Patent B2
US 7,521,233 · App. 11/675,810 · Granted Apr 21, 2009

Methods and devices for promoting endothelial morphogenesis

Assignee: Washington, University of
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,521,233
App. No.
11/675,810
Granted
Apr 21, 2009
Kind
B2
Abstract

In one aspect the present invention provides methods for promoting endothelial morphogenesis. The methods of this aspect of the invention include the step of providing to one or more endothelial cells an amount of an osteoprotegerin sufficient to promote endothelial morphogenesis. The methods of this aspect of the invention can be practiced in vivo or in vitro. In another aspect, the present invention provides implantable medical devices that each include: (a) a device body; and (b) a layer attached to a surface of the device body, the layer comprising a molecule selected from the group consisting of osteoprotegerin and a nucleic acid molecule encoding osteoprotegerin, wherein the device is adapted to be completely or partially implanted into an animal body. The implanted medical device thus promotes the growth of blood vessels in the surrounding tissue, thereby reducing or preventing the formation of a collagenous capsule around the implanted medical device.

Claims (9)

1. A method for promoting endothelial morphogenesis in vitro, said method comprising the step of providing to endothelial cells cultured on a porous matrix or scaffold that supports tissue growth in vitro an amount of an osteoprotegerin sufficient to promote endothelial morphogenesis.

2. The method of claim 1 , wherein the osteoprotegerin is at least 70% identical to the osteoprotegerin consisting of the amino acid sequence set forth in SEQ ID NO: 2.

3. The method of claim 1 , wherein the osteoprotegerin is at least 80% identical to the osteoprotegerin consisting of the amino acid sequence set forth in SEQ ID NO: 2.

4. The method of claim 1 , wherein the osteoprotegerin is at least 90% identical to the osteoprotegerin consisting of the amino acid sequence set forth in SEQ ID NO: 2.

5. The method of claim 1 , wherein the endothelial cells are cultured in a liquid medium that comprises the osteoprotegerin.

6. The method of claim 1 , wherein the endothelial morphogenesis is formation of capillaries.

7. The method of claim 1 , wherein the endothelial morphogenesis is formation of an endothelial lining in a blood vessel.

8. The method of claim 7 , wherein the endothelial lining is formed in an artificial blood vessel.

9. The method of claim 7 , wherein the endothelial lining is formed in a natural blood vessel.

Assignments (1)
CONFIRMATORY LICENSE Recorded Jun 29, 2010
From: UNIVERSITY OF WASHINGTON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024606/0502 →
Continuity (3)
Division 1014265800 · May 9, 2002
Provisional Application 6029023000 · May 10, 2001
Related Publication 20070154517A1 · Jul 5, 2007